Noninvasive assessment of characteristics of novel anti-HER2

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Anti-HER2 scFv expression, purification, and Western blot analysis. a

Molecules, Free Full-Text

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence - ScienceDirect

Therapeutic strategy for anti-Her2 and Palbociclib resistant tumors

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study - eClinicalMedicine

Herceptin-Conjugated DOX-Fe3O4/P(NIPAM-AA-MAPEG) Nanogel System for HER2-Targeted Breast Cancer Treatment and Magnetic Resonance Imaging

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)